Use and overuse of proton pump inhibitors in cirrhotic patients

Medical Science Monitor

Volumn 14, Issue 9, 2008, Pages

  Chavez Tapia, Norberto C ^a   Tellez Avila, Felix I ^a   García Leiva, Jorge ^a   Valdovinos, Miguel Angel ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Drug prescriptions; Drug utilization; Liver cirrhosis

Indexed keywords

ANTICOAGULANT AGENT; COLCHICINE; CORTICOSTEROID; PROTON PUMP INHIBITOR;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; DISEASE SEVERITY; DRUG INDICATION; DRUG MISUSE; DRUG USE; DRUG UTILIZATION; ESOPHAGUS VARICES; FEMALE; HEPATITIS C; HOSPITAL PATIENT; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCRIPTION; RETROSPECTIVE STUDY;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD CHEMICAL ANALYSIS; CHILD; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES;

EID: 52249101555     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Armstrong D: Intravenous proton pump inhibitor therapy: a rationale for use. Rev Gastroenterol Disord, 2005; 5(Suppl.2): S18-30
2. Barrison AF, Jarboe LA, Weinberg EM et al: Patterns of proton pump inhibitor use in clinical practice. Am J Med, 2001; 111: 469-73
3. Arasaradnam RP, Woodward T, Parrack L et al: Audit of proton pump inhibitor (PPI) prescribing: are NICE guidelines being followed? Clin Med, 2003; 3: 387-68
4. Delate T, Mager DE, Sheth J, Motheral BR: Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population. Am J Manag Care, 2005; 11: 29-36
5. Radhofer-Welte S: Pharmacokinetics and metabolism of the proton pump inhibitor pantoprazole in man. Drugs Today (Barc), 1999; 35: 765-72
6. Swan SK, Hoyumpa AM, Merritt GJ: Review article: the pharmacokinetics of rabeprazole in health and disease. Aliment Pharmacol Ther, 1999; 13(Suppl.3): 11-17
7. Hoyumpa AM, Trevino-Alanis H, Grimes I, Humphries TJ: Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis. Clin Ther, 1999; 21: 691-701
8. Huber R, Hartmann M, Bliesath H et al: Pharmacokinetics of pantoprazole in man. Int J Clin Pharmacol Ther, 1996; 34: S7-16
9. Ferron GM, Preston RA, Noveck RJ et al: Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction. Clin Ther, 2001; 23: 1180-42
10. Gimson A, Polson R, Westaby D, Williams R: Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy. Gastroenterology, 1990; 99: 1829-31
11. Koury SI, Stone CK, La Charite DD: Omeprazole and the development of acute hepatitis. Eur J Emerg Med, 1998; 5: 467-69
12. Nardino RJ, Vender RJ, Herbert PN: Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol, 2000; 95: 3118-22
13. Hajime K, Ryoichi N: Longterm Prevention of Esophageal Variceal Bleeding with rabeprazole: Results of a 5 Year Study in Japan. Gastroenterology, 2006; 130: A-304
14. Mendez-Sanchez N, Villa AR, Chavez-Tapia NC et al: Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol, 2005; 4: 52-55
15. Naunton M, Peterson GM, Bleasel MD: Overuse of proton pump inhibitors. J Clin Pharm Ther, 2000; 25: 333-40
16. de Franchis R: Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol, 2005; 43: 167-76
17. Moayyedi P, Talley NJ: Gastro-oesophageal reflux disease. Lancet, 2006; 367: 2086-100
18. Ji S, Kim HS, Kim JW et al: Comparison of the efficacy of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity of peptic ulcer diseases. J Gastroenterol Hepatol, 2006; 21: 1381-87
19. Dzieniszewski J, Jarosz M: Guidelines in the medical treatment of Helicobacter pylori infection. J Physiol Pharmacol, 2006; 517(Suppl.3): 143-54
20. Lanas A, Hunt R: Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies. Ann Med, 2006; 38: 415-28
21. Raghunath AS, Hungin AP, Cornford CS, Featherstone V: Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners. Digestion, 2005; 72: 212-18
22. Lucas LM, Gerrity MS, Anderson T: A practice-based approach for converting from proton pump inhibitors to less costly therapy. Eff Clin Pract, 2001; 4: 263-70
23. Walker S, Klotz U, Sarem-Aslani A, Treiber G, Bode JC: Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine. Digestion, 1991; 48: 179-84
24. Ohta M, Hashizume M, Higashi H et al: Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology, 1994; 20: 1432-36
25. Nam YJ, Kim SJ, Shin WC et al: [Gastric pH and Helicobacter pylori infection in patients with liver cirrhosis]. Korean J Hepatol, 2004; 10: 216-22
26. Savarino V, Mela GS, Zentilin P et al: Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. J Hepatol, 1996; 25: 152-57
27. Lo WC, Lin HJ, Wang K et al: Gastric secretion in Chinese patients with cirrhosis. J Clin Gastroenterol, 1996; 23: 256-60
28. Balan KK, Jones AT, Roberts NE et al: The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver. Am J Gastroenterol, 1996; 91: 1400-6
29. Bahnacy A, Kupcsulik P, Eles Z et al: Helicobacter pylori infection in congestive gastropathy. Helicobacter, 1996; 1: 168-71
30. Parikh SS, Desai SB, Prabhu SR et al: Congestive gastropathy: factors influencing development, endoscopic features, Helicobacter pylori infection, and microvessel changes. Am J Gastroenterol, 1994; 89: 1036-42
31. de Burgos Lunar C, Novo del Castillo S, Llorente Diaz E, Salinero Fort MA: [Study of prescription-indication of proton pump inhibitors]. Rev Clin Esp, 2006; 206: 266-70
32. Scagliarini R, Magnani E, Pratico A et al: Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice. Dig Dis Sci, 2005; 50: 2307-11
33. Parente F, Cucino C, Gallus S et al: Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther, 2003; 17: 1503-6